These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27020231)

  • 1. FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis.
    Lee LK; Kilcoyne A; Goldberg-Stein S; Chow DZ; Lee SI
    Semin Roentgenol; 2016 Jan; 51(1):2-11. PubMed ID: 27020231
    [No Abstract]   [Full Text] [Related]  

  • 2. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
    Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
    Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
    Lakhani A; Khan SR; Bharwani N; Stewart V; Rockall AG; Khan S; Barwick TD
    Radiographics; 2017; 37(2):577-594. PubMed ID: 28287942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinomycosis-induced adnexal and uterine masses mimicking malignancy on FDG PET/CT.
    Liu Y
    Am J Obstet Gynecol; 2019 Mar; 220(3):281. PubMed ID: 30096319
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography-computed tomography imaging for malignancies in women.
    Viswanathan C; Bhosale PR; Shah SN; Vikram R
    Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic oncologic imaging with PET/CT.
    Grant P; Sakellis C; Jacene HA
    Semin Nucl Med; 2014; 44(6):461-78. PubMed ID: 25362236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
    Yu JQ; Doss M; Alpaugh RK
    PET Clin; 2018 Apr; 13(2):249-268. PubMed ID: 29482753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.
    Sadowski EA; Pirasteh A; McMillan AB; Fowler KJ; Kusmirek JE
    Abdom Radiol (NY); 2022 Sep; 47(9):3189-3204. PubMed ID: 34687323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT and cross sectional imaging of gynecologic malignancy.
    Iyer RB; Balachandran A; Devine CE
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S130-8. PubMed ID: 17921092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT in gynecologic malignancies.
    Brunetti J
    Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in monitoring response to treatment in gynecological malignancies.
    Amit A; Person O; Keidar Z
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):17-22. PubMed ID: 23299090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecological cancers.
    Avril N; Gourtsoyianni S; Reznek R
    Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers.
    Oldan JD; Shah SN; Rose TL
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):335-350. PubMed ID: 28390533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of positron emission tomography in urological oncology.
    Rioja J; Rodríguez-Fraile M; Lima-Favaretto R; Rincón-Mayans A; Peñuelas-Sánchez I; Zudaire-Bergera JJ; Parra RO
    BJU Int; 2010 Dec; 106(11):1578-93. PubMed ID: 21078036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
    Powles T; Murray I; Brock C; Oliver T; Avril N
    Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.
    Grisaru D; Almog B; Levine C; Metser U; Fishman A; Lerman H; Lessing JB; Even-Sapir E
    Gynecol Oncol; 2004 Sep; 94(3):680-4. PubMed ID: 15350358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvis: normal variants and benign findings in FDG-PET/CT imaging.
    Kohan A; Avril NE
    PET Clin; 2014 Apr; 9(2):185-93. PubMed ID: 25030281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
    Gorospe L; Jover-Díaz R; Vicente-Bártulos A
    Abdom Imaging; 2012 Dec; 37(6):1041-65. PubMed ID: 22349805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.